Bay Harbor Wealth Management’s Emergent Biosolutions EBS Stock Holding History

Bay Harbor Wealth Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-21	Closed	-$2K	–	212
2021 Q1	$2K	Sell	21 -33	-61%	-$3.38K	﹤0.01%	194
2020 Q4	$5K	Buy	54 +34	+170%	+$3.12K	﹤0.01%	279
2020 Q3	$2K	Sell	20 -17	-46%	-$1.83K	﹤0.01%	313
2020 Q2	$3K	Hold	37	–	–	﹤0.01%	264
2020 Q1	$2K	Hold	37	–	–	﹤0.01%	263
2019 Q4	$2K	Hold	37	–	–	﹤0.01%	285
2019 Q3	$2K	Hold	37	–	–	﹤0.01%	300
2019 Q2	$2K	Hold	37	–	–	﹤0.01%	296
2019 Q1	$2K	Hold	37	–	–	﹤0.01%	334
2018 Q4	$2K	Buy	+37	New	+$2.38K	﹤0.01%	318

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bay Harbor Wealth Management's EBS Position: Q2 2021 in Review

Bay Harbor Wealth Management sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 21 shares — an estimated $2K sold.

Bay Harbor Wealth Management first reported a position in EBS in Q4 2018 and held it in 10 quarters. The position peaked at $5K in Q4 2020. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

Bay Harbor Wealth Management reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
Bay Harbor Wealth Management sold 21 Emergent Biosolutions shares in Q2 2021, an estimated $2K.
Bay Harbor Wealth Management first reported a position in Emergent Biosolutions in Q4 2018 and held it in 10 quarters.
Bay Harbor Wealth Management's Emergent Biosolutions position peaked at $5K in Q4 2020.
290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2021, filed 28 Jul 2021.